• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腺苷A(3)受体激动剂诱导HL-60人早幼粒细胞白血病细胞凋亡

Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists.

作者信息

Kohno Y, Sei Y, Koshiba M, Kim H O, Jacobson K A

机构信息

Laboratory of Bioorganic Chemistry, NIDDK, National Institutes of Health, Bethesda, Maryland 20892, USA.

出版信息

Biochem Biophys Res Commun. 1996 Feb 27;219(3):904-10. doi: 10.1006/bbrc.1996.0331.

DOI:10.1006/bbrc.1996.0331
PMID:8645277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4553948/
Abstract

The effects of adenosine (ADO) analogs on cells of the human promyelocytic HL-60 line were examined. ADO A(3) receptor agonists, N(6)-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide (IB-MECA, 30-60 microM) and 2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide (CI-IB-MECA, 10-30 microM) induced apoptotic cell death. In contrast, neither an A(1)/A(2) antagonist (XAC) nor other selective ADO receptor agonists (CPA, NECA and CGS21680) induced apoptosis at concentrations of <30 microM. Both IB-MECA and CI-IB-MECA significantly induced Ca(2+) release from intracellular Ca(2+) pools followed by Ca(2+) influx, suggesting the presence of phospholipase C-coupled ADO A(3) receptors on HL-60 cells. This was further supported by the presence of mRNA of ADO A3 receptor in the cells. These results suggest that activation of ADO A(3) receptors is responsible for the ADO-induced apoptosis in HL-60 cells and could be of potential therapeutic value in the treatment of leukemia.

摘要

研究了腺苷(ADO)类似物对人早幼粒细胞HL-60系细胞的影响。ADO A(3)受体激动剂N(6)-(3-碘苄基)腺苷-5'-N-甲基羧酰胺(IB-MECA,30 - 60微摩尔)和2-氯-N(6)-(3-碘苄基)腺苷-5'-N-甲基脲酰胺(CI-IB-MECA,10 - 30微摩尔)诱导细胞凋亡。相比之下,在浓度<30微摩尔时,A(1)/A(2)拮抗剂(XAC)以及其他选择性ADO受体激动剂(CPA、NECA和CGS21680)均未诱导细胞凋亡。IB-MECA和CI-IB-MECA均显著诱导细胞内Ca(2+)库释放Ca(2+),随后Ca(2+)内流,提示HL-60细胞上存在与磷脂酶C偶联的ADO A(3)受体。细胞中存在ADO A3受体的mRNA进一步支持了这一点。这些结果表明,ADO A(3)受体的激活是HL-60细胞中ADO诱导凋亡的原因,在白血病治疗中可能具有潜在的治疗价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461b/4553948/c5721c12e990/nihms449054f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461b/4553948/cb402ee77605/nihms449054f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461b/4553948/feefbd4760b2/nihms449054f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461b/4553948/287fc78cc683/nihms449054f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461b/4553948/c5721c12e990/nihms449054f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461b/4553948/cb402ee77605/nihms449054f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461b/4553948/feefbd4760b2/nihms449054f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461b/4553948/287fc78cc683/nihms449054f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/461b/4553948/c5721c12e990/nihms449054f4.jpg

相似文献

1
Induction of apoptosis in HL-60 human promyelocytic leukemia cells by adenosine A(3) receptor agonists.腺苷A(3)受体激动剂诱导HL-60人早幼粒细胞白血病细胞凋亡
Biochem Biophys Res Commun. 1996 Feb 27;219(3):904-10. doi: 10.1006/bbrc.1996.0331.
2
Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol.A3 腺苷受体激活诱导大鼠心肌细胞凋亡及其被异丙肾上腺素抑制
Exp Cell Res. 2000 May 25;257(1):111-26. doi: 10.1006/excr.2000.4882.
3
Adenosine A3 receptor agonists protect HL-60 and U-937 cells from apoptosis induced by A3 antagonists.腺苷A3受体激动剂可保护HL-60和U-937细胞免受A3拮抗剂诱导的凋亡。
Biochem Biophys Res Commun. 1997 Mar 17;232(2):317-22. doi: 10.1006/bbrc.1997.6290.
4
Induction of apoptosis in cardiac myocytes by an A3 adenosine receptor agonist.A3腺苷受体激动剂诱导心肌细胞凋亡
Exp Cell Res. 1998 Sep 15;243(2):383-97. doi: 10.1006/excr.1998.4134.
5
A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.一种新型腺苷类似物,硫代-Cl-IB-MECA,可诱导人早幼粒细胞白血病HL-60细胞发生G0/G1期细胞周期阻滞并凋亡。
Biochem Pharmacol. 2005 Sep 15;70(6):918-24. doi: 10.1016/j.bcp.2005.06.017.
6
Pharmacological analysis of calcium responses mediated by the human A3 adenosine receptor in monocyte-derived dendritic cells and recombinant cells.人A3腺苷受体介导的单核细胞衍生树突状细胞和重组细胞中钙反应的药理学分析。
Mol Pharmacol. 2003 Feb;63(2):342-50. doi: 10.1124/mol.63.2.342.
7
Apoptosis induced by adenosine in human leukemia HL-60 cells.
Exp Cell Res. 1994 Jul;213(1):242-52. doi: 10.1006/excr.1994.1196.
8
Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium.人类嗜酸性粒细胞上A3腺苷受体的激活会提高细胞内钙水平。
Blood. 1996 Nov 1;88(9):3569-74.
9
p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA.腺苷衍生物Cl-IB-MECA对白血病细胞中Fas和凋亡的p53非依赖性诱导作用
Biochem Pharmacol. 2002 Mar 1;63(5):871-80. doi: 10.1016/s0006-2952(02)00839-0.
10
The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca²⁺/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells.激动剂 Cl-IB-MECA 通过依赖 Ca²⁺/ROS 的 ERK 和 Akt 下调诱导 A172 人神经胶质瘤细胞死亡。
Neurochem Res. 2012 Dec;37(12):2667-77. doi: 10.1007/s11064-012-0855-5. Epub 2012 Aug 10.

引用本文的文献

1
Adenosine A and A Receptors: Distinct Cardioprotection.腺苷A1和A2受体:不同的心脏保护作用。
Drug Dev Res. 2001 Jan-Feb;52(1-2):366-378. doi: 10.1002/ddr.1136.
2
Genetic and functional modulation by agonist MRS5698 and allosteric enhancer LUF6000 at the native A adenosine receptor in HL-60 cells.在 HL-60 细胞中原位 A 腺苷受体上激动剂 MRS5698 和别构增强剂 LUF6000 的遗传和功能调节。
Purinergic Signal. 2024 Oct;20(5):559-570. doi: 10.1007/s11302-024-09992-z. Epub 2024 Feb 28.
3
Purinoceptors in the Central Nervous System.中枢神经系统中的嘌呤受体。
Drug Dev Res. 1996 Nov-Dec;39(3-4):361-370. doi: 10.1002/(sici)1098-2299(199611/12)39:3/4<361::aid-ddr17>3.0.co;2-4.
4
Adenosine A Receptors and Viability of Astrocytes.腺苷A受体与星形胶质细胞的活力
Drug Dev Res. 1998 Nov-Dec;45(3-4):379-386. doi: 10.1002/(sici)1098-2299(199811/12)45:3/4<379::aid-ddr38>3.0.co;2-y.
5
Recent Developments in Selective Agonists and Antagonists Acting at Purine and Pyrimidine Receptors.作用于嘌呤和嘧啶受体的选择性激动剂和拮抗剂的最新进展。
Drug Dev Res. 1996 Nov-Dec;39(3-4):289-300. doi: 10.1002/(sici)1098-2299(199611/12)39:3/4<289::aid-ddr8>3.0.co;2-n.
6
The Anti-Cancer Effect of A Adenosine Receptor Agonists: A Novel, Targeted Therapy.A腺苷受体激动剂的抗癌作用:一种新型靶向治疗
Immunol Endocr Metab Agents Med Chem. 2007 Aug;7:298-303. doi: 10.2174/187152207781369878.
7
A Adenosine Receptors: Protective vs. Damaging Effects Identified Using Novel Agonists and Antagonists.A 腺苷受体:使用新型激动剂和拮抗剂确定的保护作用与损伤作用
Drug Dev Res. 1998 Nov-Dec;45(3-4):113-124. doi: 10.1002/(SICI)1098-2299(199811/12)45:3/4<113::AID-DDR5>3.0.CO;2-S. Epub 1999 Mar 1.
8
Design, Synthesis and Evaluation of New Indolylpyrimidylpiperazines for Gastrointestinal Cancer Therapy.新型吲哚基嘧啶基哌嗪的设计、合成与评价及其在胃肠道癌症治疗中的应用。
Molecules. 2019 Oct 11;24(20):3661. doi: 10.3390/molecules24203661.
9
Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.细胞外三磷酸腺苷和腺苷在肿瘤-宿主相互作用中的多方面影响及治疗前景
Front Immunol. 2017 Nov 14;8:1526. doi: 10.3389/fimmu.2017.01526. eCollection 2017.
10
A Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.腺嘌呤受体作为炎症的调节剂:从药物化学到治疗。
Med Res Rev. 2018 Jul;38(4):1031-1072. doi: 10.1002/med.21456. Epub 2017 Jul 6.

本文引用的文献

1
A-adenosine receptors: design of selective ligands and therapeutic prospects.A 型腺苷受体:选择性配体的设计与治疗前景
Drugs Future. 1995 Jul;20(7):689-699. doi: 10.1358/dof.1995.020.07.531583.
2
G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain.大鼠脑中腺苷A3受体通过G蛋白依赖性激活磷脂酶C
Mol Pharmacol. 1995 Dec;48(6):1038-45.
3
cDNA cloning and sequence analysis of the human A3 adenosine receptor.
Biochim Biophys Acta. 1993 Oct 7;1179(1):105-7. doi: 10.1016/0167-4889(93)90077-3.
4
Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.具有广泛组织分布的绵羊A3腺苷受体的分子克隆与功能表达
Mol Pharmacol. 1993 Sep;44(3):524-32.
5
The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells.A3 腺苷受体是唯一能促进肥大细胞释放过敏介质的腺苷受体。
J Biol Chem. 1993 Aug 15;268(23):16887-90.
6
The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents.HL-60细胞对各种抗肿瘤药物诱导凋亡的敏感性与细胞周期相关的差异。
Cancer Res. 1993 Jul 1;53(13):3186-92.
7
Molecular cloning and characterization of the human A3 adenosine receptor.人类A3腺苷受体的分子克隆与特性分析
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10365-9. doi: 10.1073/pnas.90.21.10365.
8
Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.N6-苄基腺苷-5'-脲酰胺作为A3选择性腺苷激动剂的构效关系
J Med Chem. 1994 Mar 4;37(5):636-46. doi: 10.1021/jm00031a014.
9
Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2'-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine.
Blood. 1993 Jan 1;81(1):143-50.
10
Internucleosomal DNA fragmentation in gerbil hippocampus following forebrain ischemia.
Neurosci Lett. 1994 Apr 25;171(1-2):179-82. doi: 10.1016/0304-3940(94)90634-3.